TABLE 1.
Description of full study cohort
| Parameter | HIV-negative MSW | |||||
|---|---|---|---|---|---|---|
| HIV-negative MSM | HIV-positive MSM, untreated | HIV-positive MSM, treated | HIV-positive MSM, treated, with LD | Pb | ||
| No. of subjects | 22 | 32 | 14 | 20 | 25 | |
| Median (IQR)a | ||||||
| Age, yr | 33 (27.3–38.5) | 34 (29.8–44.5) | 34 (26.5–40.3) | 46 (42.8–50.5) | 60 (54–64) | *** |
| BMI, kg/m2 | 25.2 (23.0–27.0) | 25.5 (20.2–28.0) | 21.4 (20.2–25.6) | 23.9 (22.6–26.2) | 25.8 (23.0–28.0) | NS |
| CD4 cell count | NA | NA | 538 (406–732) | 586 (420–878) | 659 (550–908) | NS |
| CD4 nadir count | NA | NA | 496 (409–612) | 256 (118–416) | 152 (70–350) | *** |
| Viral load (copies/ml) | NA | NA | 101,400 (20,300–292,514) | 20 (0–20) | 0 (0–20) | *** |
| Cholesterol drugs/statins, n (%) | 2 (9.1) | 3 (9.4) | 1 (7.1) | 4 (20) | 14 (56) | +++ |
a
Numbers are reported as medians and interquartile ranges (IQR).
b
P values were determined using the Kruskal-Wallis test (***, P < 0.001; NS, P > 0.05) and Fisher exact test (+++, P < 0.001). See Table S1 for pairwise comparisons between groups.